chr11-2572021-G-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_000218.3(KCNQ1):c.692G>T(p.Arg231Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000000685 in 1,460,216 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R231C) has been classified as Pathogenic.
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNQ1 | NM_000218.3 | c.692G>T | p.Arg231Leu | missense_variant | 5/16 | ENST00000155840.12 | NP_000209.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.692G>T | p.Arg231Leu | missense_variant | 5/16 | 1 | NM_000218.3 | ENSP00000155840.2 | ||
KCNQ1 | ENST00000335475.6 | c.311G>T | p.Arg104Leu | missense_variant | 5/16 | 1 | ENSP00000334497.5 | |||
KCNQ1 | ENST00000496887.7 | c.431G>T | p.Arg144Leu | missense_variant | 6/16 | 5 | ENSP00000434560.2 | |||
KCNQ1 | ENST00000646564.2 | c.478-11414G>T | intron_variant | ENSP00000495806.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460216Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 726432
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 15, 2016 | The p.R231L variant (also known as c.692G>T), located in coding exon 5 of the KCNQ1 gene, results from a G to T substitution at nucleotide position 692. The arginine at codon 231 is replaced by leucine, an amino acid with dissimilar properties. Although the p.R231L variant has not been reported previously, alterations affecting the same amino acid (p.R231H and p.R231C) have been identified in multiple individuals with long QT syndrome (LQTS), atrial fibrillation (AF), and/or bradycardia (Lupoglazoff JM et al. J. Am. Coll. Cardiol. 2004 Mar; 43(5):826-30; Napolitano C et al. JAMA 2005 Dec; 294(23):2975-80; Bartos DC et al. Heart Rhythm 2011 Jan; 8(1):48-55; Henrion U et al. Cell. Physiol. Biochem. 2012 May; 29(5-6):809-18; Bartos DC et al. J. Cardiovasc. Electrophysiol. 2013 May; 24(5):562-9; Guerrier K et al. Heart Rhythm 2013 Sep; 10(9):1351-3). The p.R231L variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), Exome Aggregation Consortium (ExAC), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6498 samples (12996 alleles) with coverage at this position. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at